| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |